These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 37272727)

  • 21. Therapeutic cancer vaccine therapy for acute myeloid leukemia.
    Wu M; Wang S; Chen JY; Zhou LJ; Guo ZW; Li YH
    Immunotherapy; 2021 Jul; 13(10):863-877. PubMed ID: 33955237
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute lymphoblastic leukaemia: correlation between morphological/immunohistochemical and molecular biological findings in bone marrow biopsy specimens.
    Kröber SM; Greschniok A; Kaiserling E; Horny HP
    Mol Pathol; 2000 Apr; 53(2):83-7. PubMed ID: 10889907
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Using immunotherapy and novel trial designs to optimise front-line therapy in adult acute lymphoblastic leukaemia: breaking with the traditions of the past.
    Short NJ; Kantarjian H
    Lancet Haematol; 2023 May; 10(5):e382-e388. PubMed ID: 37003279
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immune-Based Therapeutic Interventions for Acute Myeloid Leukemia.
    Perna F; Espinoza-Gutarra MR; Bombaci G; Farag SS; Schwartz JE
    Cancer Treat Res; 2022; 183():225-254. PubMed ID: 35551662
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immune therapies in acute myeloid leukemia: a focus on monoclonal antibodies and immune checkpoint inhibitors.
    Assi R; Kantarjian H; Ravandi F; Daver N
    Curr Opin Hematol; 2018 Mar; 25(2):136-145. PubMed ID: 29206680
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Progress in biology and therapy of acute lymphoblastic leukemia].
    Robak T
    Postepy Hig Med Dosw; 1989; 43(2-4):291-328. PubMed ID: 2702356
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel Approaches to Acute Myeloid Leukemia Immunotherapy.
    Beyar-Katz O; Gill S
    Clin Cancer Res; 2018 Nov; 24(22):5502-5515. PubMed ID: 29903894
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunomodulatory Drugs: Immune Checkpoint Agents in Acute Leukemia.
    Knaus HA; Kanakry CG; Luznik L; Gojo I
    Curr Drug Targets; 2017; 18(3):315-331. PubMed ID: 25981611
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safe and effective off-the-shelf immunotherapy based on CAR.CD123-NK cells for the treatment of acute myeloid leukaemia.
    Caruso S; De Angelis B; Del Bufalo F; Ciccone R; Donsante S; Volpe G; Manni S; Guercio M; Pezzella M; Iaffaldano L; Silvestris DA; Sinibaldi M; Di Cecca S; Pitisci A; Velardi E; Merli P; Algeri M; Lodi M; Paganelli V; Serafini M; Riminucci M; Locatelli F; Quintarelli C
    J Hematol Oncol; 2022 Nov; 15(1):163. PubMed ID: 36335396
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute myeloid leukemia and novel biological treatments: monoclonal antibodies and cell-based gene-modified immune effectors.
    Tettamanti S; Magnani CF; Biondi A; Biagi E
    Immunol Lett; 2013; 155(1-2):43-6. PubMed ID: 24076117
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Role of T Cell Immunotherapy in Acute Myeloid Leukemia.
    Hao F; Sholy C; Wang C; Cao M; Kang X
    Cells; 2021 Dec; 10(12):. PubMed ID: 34943884
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Redirecting Specificity of T cells Using the Sleeping Beauty System to Express Chimeric Antigen Receptors by Mix-and-Matching of VL and VH Domains Targeting CD123+ Tumors.
    Thokala R; Olivares S; Mi T; Maiti S; Deniger D; Huls H; Torikai H; Singh H; Champlin RE; Laskowski T; McNamara G; Cooper LJ
    PLoS One; 2016; 11(8):e0159477. PubMed ID: 27548616
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The future of cellular immunotherapy for childhood leukemia.
    Bonifant CL; Tasian SK
    Curr Opin Pediatr; 2020 Feb; 32(1):13-25. PubMed ID: 31851053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Bispecific antibodies in onco-hematology: Applications and perspectives].
    Barrière S; El-Ghazzi N; Garcia M; Guièze R
    Bull Cancer; 2021 Oct; 108(10S):S195-S204. PubMed ID: 34920803
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monoclonal antibodies and immune therapies for adult precursor B-acute lymphoblastic leukemia.
    Sikaria S; Aldoss I; Akhtari M
    Immunol Lett; 2016 Apr; 172():113-23. PubMed ID: 26921100
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Investigational immunotherapy targeting CD19 for the treatment of acute lymphoblastic leukemia.
    Viardot A; Sala E
    Expert Opin Investig Drugs; 2021 Jul; 30(7):773-784. PubMed ID: 33998346
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relapse after allogeneic bone marrow transplantation for acute leukaemia: a survey by the E.B.M.T. of 117 cases.
    Frassoni F; Barrett AJ; Grañena A; Ernst P; Garthon G; Kolb HJ; Prentice HG; Vernant JP; Zwaan FE; Gratwohl A
    Br J Haematol; 1988 Nov; 70(3):317-20. PubMed ID: 3061443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Escape from T-cell-targeting immunotherapies in acute myeloid leukemia.
    Vadakekolathu J; Rutella S
    Blood; 2024 Jun; 143(26):2689-2700. PubMed ID: 37467496
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene transfer to primary acute myeloid leukaemia blasts and myeloid leukaemia cell lines.
    Roddie PH; Paterson T; Turner ML
    Cytokines Cell Mol Ther; 2000 Sep; 6(3):127-34. PubMed ID: 11140881
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The novel bispecific diabody alphaCD40/alphaCD28 strengthens leukaemic dendritic cell-induced T-cell reactivity.
    Houtenbos I; Santegoets S; Westers TM; Waisfisz Q; Kipriyanov S; Denkers F; Scheper RJ; de Gruijl TD; Ossenkoppele GJ; van de Loosdrecht AA
    Br J Haematol; 2008 Jun; 142(2):273-83. PubMed ID: 18492117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.